SEVERINO MICHAEL
SEC insider (Form 3/4/5 filer). CIK 0001609447. Chief Executive Officer at Sarepta Therapeutics, Inc. (SRPT) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in MA.
Companies SEVERINO MICHAEL has filed insider reports for
- Sarepta Therapeutics, Inc. (SRPT): Director, Officer, Chief Executive Officer
- Avantor, Inc. (AVTR): Director
- Viatris Inc (VTRS): Director
SEVERINO MICHAEL
CIK: 0001609447
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (28.6%)
Derivative conversions
Awards (A)5 (71.4%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 28, 2026SRPT
Sarepta Therapeutics, Inc.
AwardDirect756.1K shares- - May 7, 2026AVTR
Avantor, Inc.
AwardDirect25.3K shares- - Mar 6, 2026VTRS
Viatris Inc
ExerciseDirect919 shares- - Mar 6, 2026VTRS
Viatris Inc
ExerciseDirect25.1K shares- - Mar 6, 2026VTRS
Viatris Inc
AwardDirectRestricted Stock Units
15.9K shares- - May 12, 2025VTRS
Viatris Inc
AwardDirectRestricted Stock Units
25.1K shares- - May 8, 2025AVTR
Avantor, Inc.
AwardDirect17.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award | 756,104 | - | $0 | Direct |
| May 7, 2026 |  AVTR Avantor, Inc. | Award | 25,270 | - | $0 | Direct |
| Mar 6, 2026 |  VTRS Viatris Inc | Exercise | 919 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Exercise | 25,112 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Award Restricted Stock Units | 15,890 | - | - | Direct |
| May 12, 2025 | VTRS Viatris Inc | Award Restricted Stock Units | 25,112 | - | - | Direct |
| May 8, 2025 | AVTR Avantor, Inc. | Award | 17,100 | - | - | Direct |
1-7 of 7 transactions